1. Home
  2. SEPN vs BRDG Comparison

SEPN vs BRDG Comparison

Compare SEPN & BRDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • BRDG
  • Stock Information
  • Founded
  • SEPN 2022
  • BRDG 2009
  • Country
  • SEPN United States
  • BRDG United States
  • Employees
  • SEPN N/A
  • BRDG N/A
  • Industry
  • SEPN
  • BRDG Investment Managers
  • Sector
  • SEPN
  • BRDG Finance
  • Exchange
  • SEPN NYSE
  • BRDG Nasdaq
  • Market Cap
  • SEPN 453.2M
  • BRDG 391.6M
  • IPO Year
  • SEPN 2024
  • BRDG 2021
  • Fundamental
  • Price
  • SEPN $10.41
  • BRDG $9.50
  • Analyst Decision
  • SEPN Buy
  • BRDG Hold
  • Analyst Count
  • SEPN 4
  • BRDG 5
  • Target Price
  • SEPN $27.00
  • BRDG $11.30
  • AVG Volume (30 Days)
  • SEPN 559.2K
  • BRDG 311.4K
  • Earning Date
  • SEPN 08-15-2025
  • BRDG 08-05-2025
  • Dividend Yield
  • SEPN N/A
  • BRDG 4.85%
  • EPS Growth
  • SEPN N/A
  • BRDG N/A
  • EPS
  • SEPN N/A
  • BRDG N/A
  • Revenue
  • SEPN $977,000.00
  • BRDG $453,729,000.00
  • Revenue This Year
  • SEPN N/A
  • BRDG N/A
  • Revenue Next Year
  • SEPN $526.96
  • BRDG $36.21
  • P/E Ratio
  • SEPN N/A
  • BRDG N/A
  • Revenue Growth
  • SEPN 108.76
  • BRDG 39.05
  • 52 Week Low
  • SEPN $4.17
  • BRDG $6.82
  • 52 Week High
  • SEPN $28.99
  • BRDG $11.69
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • BRDG 52.05
  • Support Level
  • SEPN N/A
  • BRDG $9.28
  • Resistance Level
  • SEPN N/A
  • BRDG $9.83
  • Average True Range (ATR)
  • SEPN 0.00
  • BRDG 0.20
  • MACD
  • SEPN 0.00
  • BRDG 0.00
  • Stochastic Oscillator
  • SEPN 0.00
  • BRDG 61.18

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

About BRDG Bridge Investment Group Holdings Inc.

Bridge Investment Group Holdings Inc is a vertically integrated investment manager, diversified across specialized asset classes. The company combines its operating platform with dedicated teams of investment professionals focused on various specialized and synergistic investment platforms, including real estate, credit, renewable energy, and secondaries strategies. Its products and vertically integrated structure allow it to capture new market opportunities and serve investors with various investment objectives. The Company operates as one business, a fully integrated real estate investment manager.

Share on Social Networks: